 |
 |

Reporting of Randomized Clinical Trials and Other Population-Based Research
A Priority of Archives of Neurology
Arch Neurol. 2004;61:20-21.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
The maturation of neuroscience, insights into fundamental mechanisms, and applications of molecular genetics and cellular biology have fueled an unprecedented opportunity to carry out population-based clinical research aimed at identifying key risk factors and therapeutic interventions to relieve the burden of neurologic disease. The reporting of population-based clinical research, particularly of randomized controlled trials (RCTs), represents the final common pathway for translational research and the accrued knowledge base for our health and public policies. The Archives of Neurology editorial board is mindful of this importance and places high priority on the solicitation and publication of excellent reports of RCTs and other population-based neurologic research.
Excellent reporting is primarily dependent on the quality standards of the reported research. We seek well-conceived and scientifically grounded clinical research studies that are controlled and fashioned by statistical expertise, a documented protocol, and a prespecified plan of analysis. To aid comprehension and assessment of RCTs, . . . [Full Text of this Article]
Ira Shoulson, MD
Department of Neurology University of Rochester 1351 Mount Hope Ave, Suite 218 Rochester, NY 14618
Roger N. Rosenberg, MD, Editor
|